10-Q Filing

UNITEDHEALTH GROUP INC CIK: 731766 Q3 2023

Filing Information

Form Type	10-Q
Accession Number	`0000731766-23-000064`
Period End Date	20230930
Filing Date	20231106
Fiscal Year	2023
Fiscal Period	Q3
XBRL Instance	unh-20230930_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 86 Income Statement 84 Cash Flow Statement 73 Stockholders Equity 63 Comprehensive Income 48

Balance Sheet 86 line items

Line Item	Tag	Value	Unit	Period
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$23.36B	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$38.91B	USD	Point-in-time
Short-term investments	`ShortTermInvestments`	$4.55B	USD	Point-in-time
Short-term investments	`ShortTermInvestments`	$5.18B	USD	Point-in-time
Accounts receivable, net	`AccountsReceivableNetCurrent`	$20.67B	USD	Point-in-time
Accounts receivable, net	`AccountsReceivableNetCurrent`	$17.68B	USD	Point-in-time
Other current receivables, net	`OtherReceivablesNetCurrent`	$17.75B	USD	Point-in-time
Other current receivables, net	`OtherReceivablesNetCurrent`	$12.77B	USD	Point-in-time
Assets under management	`AarpAssetsUnderManagement`	$3.62B	USD	Point-in-time
Assets under management	`AarpAssetsUnderManagement`	$4.09B	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$5.77B	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$6.62B	USD	Point-in-time
Total current assets	`AssetsCurrent`	$91.91B	USD	Point-in-time
Total current assets	`AssetsCurrent`	$69.07B	USD	Point-in-time
Long-term investments	`LongTermInvestments`	$45.47B	USD	Point-in-time
Long-term investments	`LongTermInvestments`	$43.73B	USD	Point-in-time
Property, equipment and capitalized software, net	`PropertyPlantAndEquipmentNet`	$11.07B	USD	Point-in-time
Property, equipment and capitalized software, net	`PropertyPlantAndEquipmentNet`	$10.13B	USD	Point-in-time
Goodwill	`Goodwill`	$101.70B	USD	Point-in-time
Goodwill	`Goodwill`	$93.35B	USD	Point-in-time
Other intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$15.20B	USD	Point-in-time
Other intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$14.40B	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$15.03B	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$16.71B	USD	Point-in-time
Total assets	`Assets`	$245.71B	USD	Point-in-time
Total assets	`Assets`	$282.06B	USD	Point-in-time
Medical costs payable	`LiabilityForClaimsAndClaimsAdjustmentExpense`	$32.79B	USD	Point-in-time
Medical costs payable	`LiabilityForClaimsAndClaimsAdjustmentExpense`	$29.06B	USD	Point-in-time
Medical costs payable	`LiabilityForClaimsAndClaimsAdjustmentExpense`	$24.48B	USD	Point-in-time
Medical costs payable	`LiabilityForClaimsAndClaimsAdjustmentExpense`	$29.06B	USD	Point-in-time
Accounts payable and accrued liabilities	`AccountsPayableAndAccruedLiabilitiesCurrent`	$27.71B	USD	Point-in-time
Accounts payable and accrued liabilities	`AccountsPayableAndAccruedLiabilitiesCurrent`	$31.16B	USD	Point-in-time
Short-term borrowings and current maturities of long-term debt	`DebtCurrent`	$3.11B	USD	Point-in-time
Short-term borrowings and current maturities of long-term debt	`DebtCurrent`	$5.29B	USD	Point-in-time
Unearned revenues	`DeferredRevenueCurrent`	$3.08B	USD	Point-in-time
Unearned revenues	`DeferredRevenueCurrent`	$15.31B	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$29.62B	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$26.28B	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$89.24B	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$114.18B	USD	Point-in-time
Long-term debt, less current maturities	`LongTermDebtNoncurrent`	$58.08B	USD	Point-in-time
Long-term debt, less current maturities	`LongTermDebtNoncurrent`	$54.51B	USD	Point-in-time
Deferred income taxes	`DeferredIncomeTaxLiabilitiesNet`	$2.21B	USD	Point-in-time
Deferred income taxes	`DeferredIncomeTaxLiabilitiesNet`	$2.77B	USD	Point-in-time
Other liabilities	`OtherLiabilitiesNoncurrent`	$12.84B	USD	Point-in-time
Other liabilities	`OtherLiabilitiesNoncurrent`	$13.62B	USD	Point-in-time
Total liabilities	`Liabilities`	$188.08B	USD	Point-in-time
Total liabilities	`Liabilities`	$159.36B	USD	Point-in-time
Commitments and contingencies (Note 7)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (Note 7)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Redeemable noncontrolling interests	`RedeemableNoncontrollingInterestEquityCarryingAmount`	$4.90B	USD	Point-in-time
Redeemable noncontrolling interests	`RedeemableNoncontrollingInterestEquityCarryingAmount`	$4.42B	USD	Point-in-time
Preferred stock, $0.001 par value - 10 shares authorized; no shares issued or outstanding	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, $0.001 par value - 10 shares authorized; no shares issued or outstanding	`PreferredStockValue`	-	USD	Point-in-time
Common stock, $0.01 par value - 3,000 shares authorized; 925 and 934 issued and outstanding	`CommonStockValue`	$9.00M	USD	Point-in-time
Common stock, $0.01 par value - 3,000 shares authorized; 925 and 934 issued and outstanding	`CommonStockValue`	$9.00M	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$86.16B	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$93.17B	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-8.69B	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-8.39B	USD	Point-in-time
Nonredeemable noncontrolling interests	`MinorityInterest`	$5.07B	USD	Point-in-time
Nonredeemable noncontrolling interests	`MinorityInterest`	$3.68B	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$89.56B	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$87.37B	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$76.20B	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$81.45B	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$78.06B	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$75.05B	USD	Point-in-time
Total liabilities, redeemable noncontrolling interests and equity	`LiabilitiesAndStockholdersEquity`	$245.71B	USD	Point-in-time
Total liabilities, redeemable noncontrolling interests and equity	`LiabilitiesAndStockholdersEquity`	$282.06B	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	3.00B	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	3.00B	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	934.00M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	925.00M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	925.00M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	934.00M	shares	Point-in-time

Income Statement 84 line items

Line Item	Tag	Value	Unit	Period
Premiums	`PremiumsEarnedNet`	$217.60B	USD	3 Qtrs
Premiums	`PremiumsEarnedNet`	$72.34B	USD	1 Quarter
Premiums	`PremiumsEarnedNet`	$192.46B	USD	3 Qtrs
Premiums	`PremiumsEarnedNet`	$64.49B	USD	1 Quarter
Investment and other income	`InvestmentIncomeInterestAndDividend`	$997.00M	USD	1 Quarter
Investment and other income	`InvestmentIncomeInterestAndDividend`	$2.91B	USD	3 Qtrs
Investment and other income	`InvestmentIncomeInterestAndDividend`	$1.18B	USD	3 Qtrs
Investment and other income	`InvestmentIncomeInterestAndDividend`	$513.00M	USD	1 Quarter
Total revenues	`Revenues`	$241.38B	USD	3 Qtrs
Total revenues	`Revenues`	$80.89B	USD	1 Quarter
Total revenues	`Revenues`	$277.19B	USD	3 Qtrs
Total revenues	`Revenues`	$92.36B	USD	1 Quarter
Medical costs	`PolicyholderBenefitsAndClaimsIncurredHealthCare`	$157.25B	USD	3 Qtrs
Medical costs	`PolicyholderBenefitsAndClaimsIncurredHealthCare`	$179.66B	USD	3 Qtrs
Medical costs	`PolicyholderBenefitsAndClaimsIncurredHealthCare`	$59.55B	USD	1 Quarter
Medical costs	`PolicyholderBenefitsAndClaimsIncurredHealthCare`	$52.63B	USD	1 Quarter
Operating costs	`SellingGeneralAndAdministrativeExpense`	$11.66B	USD	1 Quarter
Operating costs	`SellingGeneralAndAdministrativeExpense`	$41.29B	USD	3 Qtrs
Operating costs	`SellingGeneralAndAdministrativeExpense`	$13.86B	USD	1 Quarter
Operating costs	`SellingGeneralAndAdministrativeExpense`	$34.77B	USD	3 Qtrs
Cost of products sold	`CostOfGoodsAndServicesSold`	$9.42B	USD	1 Quarter
Cost of products sold	`CostOfGoodsAndServicesSold`	$8.31B	USD	1 Quarter
Cost of products sold	`CostOfGoodsAndServicesSold`	$25.39B	USD	3 Qtrs
Cost of products sold	`CostOfGoodsAndServicesSold`	$28.58B	USD	3 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$1.01B	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$828.00M	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$2.42B	USD	3 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$3.00B	USD	3 Qtrs
Total operating costs	`CostsAndExpenses`	$83.83B	USD	1 Quarter
Total operating costs	`CostsAndExpenses`	$219.83B	USD	3 Qtrs
Total operating costs	`CostsAndExpenses`	$252.53B	USD	3 Qtrs
Total operating costs	`CostsAndExpenses`	$73.43B	USD	1 Quarter
Earnings from operations	`OperatingIncomeLoss`	$21.54B	USD	3 Qtrs
Earnings from operations	`OperatingIncomeLoss`	$7.46B	USD	1 Quarter
Earnings from operations	`OperatingIncomeLoss`	$24.67B	USD	3 Qtrs
Earnings from operations	`OperatingIncomeLoss`	$8.53B	USD	1 Quarter
Interest expense	`InterestExpense`	$834.00M	USD	1 Quarter
Interest expense	`InterestExpense`	$2.42B	USD	3 Qtrs
Interest expense	`InterestExpense`	$1.42B	USD	3 Qtrs
Interest expense	`InterestExpense`	$516.00M	USD	1 Quarter
Earnings before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$7.69B	USD	1 Quarter
Earnings before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$20.13B	USD	3 Qtrs
Earnings before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$6.95B	USD	1 Quarter
Earnings before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$22.25B	USD	3 Qtrs
Provision for income taxes	`IncomeTaxExpenseBenefit`	$1.65B	USD	1 Quarter
Provision for income taxes	`IncomeTaxExpenseBenefit`	$1.56B	USD	1 Quarter
Provision for income taxes	`IncomeTaxExpenseBenefit`	$4.78B	USD	3 Qtrs
Provision for income taxes	`IncomeTaxExpenseBenefit`	$4.40B	USD	3 Qtrs
Net earnings	`ProfitLoss`	$17.47B	USD	3 Qtrs
Net earnings	`ProfitLoss`	$15.73B	USD	3 Qtrs
Net earnings	`ProfitLoss`	$5.38B	USD	1 Quarter
Net earnings	`ProfitLoss`	$6.04B	USD	1 Quarter
Earnings attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$543.00M	USD	3 Qtrs
Earnings attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$197.00M	USD	1 Quarter
Earnings attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$372.00M	USD	3 Qtrs
Earnings attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$122.00M	USD	1 Quarter
Net earnings attributable to UnitedHealth Group common shareholders	`NetIncomeLoss`	$5.26B	USD	1 Quarter
Net earnings attributable to UnitedHealth Group common shareholders	`NetIncomeLoss`	$15.36B	USD	3 Qtrs
Net earnings attributable to UnitedHealth Group common shareholders	`NetIncomeLoss`	$16.93B	USD	3 Qtrs
Net earnings attributable to UnitedHealth Group common shareholders	`NetIncomeLoss`	$5.84B	USD	1 Quarter
Basic	`EarningsPerShareBasic`	$16.37	USD	3 Qtrs
Basic	`EarningsPerShareBasic`	$5.63	USD	1 Quarter
Basic	`EarningsPerShareBasic`	$18.20	USD	3 Qtrs
Basic	`EarningsPerShareBasic`	$6.31	USD	1 Quarter
Diluted	`EarningsPerShareDiluted`	$5.55	USD	1 Quarter
Diluted	`EarningsPerShareDiluted`	$6.24	USD	1 Quarter
Diluted	`EarningsPerShareDiluted`	$18.01	USD	3 Qtrs
Diluted	`EarningsPerShareDiluted`	$16.15	USD	3 Qtrs
Basic weighted-average number of common shares outstanding	`WeightedAverageNumberOfSharesOutstandingBasic`	926.00M	shares	1 Quarter
Basic weighted-average number of common shares outstanding	`WeightedAverageNumberOfSharesOutstandingBasic`	930.00M	shares	3 Qtrs
Basic weighted-average number of common shares outstanding	`WeightedAverageNumberOfSharesOutstandingBasic`	938.00M	shares	3 Qtrs
Basic weighted-average number of common shares outstanding	`WeightedAverageNumberOfSharesOutstandingBasic`	935.00M	shares	1 Quarter
Dilutive effect of common share equivalents	`WeightedAverageNumberDilutedSharesOutstandingAdjustment`	10.00M	shares	1 Quarter
Dilutive effect of common share equivalents	`WeightedAverageNumberDilutedSharesOutstandingAdjustment`	10.00M	shares	3 Qtrs
Dilutive effect of common share equivalents	`WeightedAverageNumberDilutedSharesOutstandingAdjustment`	13.00M	shares	3 Qtrs
Dilutive effect of common share equivalents	`WeightedAverageNumberDilutedSharesOutstandingAdjustment`	13.00M	shares	1 Quarter
Diluted weighted-average number of common shares outstanding	`WeightedAverageNumberOfDilutedSharesOutstanding`	951.00M	shares	3 Qtrs
Diluted weighted-average number of common shares outstanding	`WeightedAverageNumberOfDilutedSharesOutstanding`	948.00M	shares	1 Quarter
Diluted weighted-average number of common shares outstanding	`WeightedAverageNumberOfDilutedSharesOutstanding`	940.00M	shares	3 Qtrs
Diluted weighted-average number of common shares outstanding	`WeightedAverageNumberOfDilutedSharesOutstanding`	936.00M	shares	1 Quarter
Anti-dilutive shares excluded from the calculation of dilutive effect of common share equivalents	`AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount`	3.00M	shares	1 Quarter
Anti-dilutive shares excluded from the calculation of dilutive effect of common share equivalents	`AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount`	6.00M	shares	1 Quarter
Anti-dilutive shares excluded from the calculation of dilutive effect of common share equivalents	`AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount`	6.00M	shares	3 Qtrs
Anti-dilutive shares excluded from the calculation of dilutive effect of common share equivalents	`AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount`	3.00M	shares	3 Qtrs

Cash Flow Statement 73 line items

Line Item	Tag	Value	Unit	Period
Net earnings	`ProfitLoss`	$17.47B	USD	3 Qtrs
Net earnings	`ProfitLoss`	$15.73B	USD	3 Qtrs
Net earnings	`ProfitLoss`	$5.38B	USD	1 Quarter
Net earnings	`ProfitLoss`	$6.04B	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$1.01B	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$828.00M	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$2.42B	USD	3 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$3.00B	USD	3 Qtrs
Deferred income taxes	`DeferredIncomeTaxExpenseBenefit`	$-494.00M	USD	3 Qtrs
Deferred income taxes	`DeferredIncomeTaxExpenseBenefit`	$-590.00M	USD	3 Qtrs
Share-based compensation	`ShareBasedCompensation`	$675.00M	USD	3 Qtrs
Share-based compensation	`ShareBasedCompensation`	$851.00M	USD	3 Qtrs
Other, net	`OtherNoncashIncomeExpense`	-	USD	3 Qtrs
Other, net	`OtherNoncashIncomeExpense`	$59.00M	USD	3 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$2.57B	USD	3 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$2.56B	USD	3 Qtrs
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$741.00M	USD	3 Qtrs
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$2.36B	USD	3 Qtrs
Medical costs payable	`IncreaseDecreaseInHealthCareInsuranceLiabilities`	$4.19B	USD	3 Qtrs
Medical costs payable	`IncreaseDecreaseInHealthCareInsuranceLiabilities`	$3.84B	USD	3 Qtrs
Accounts payable and other liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$2.37B	USD	3 Qtrs
Accounts payable and other liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$1.42B	USD	3 Qtrs
Unearned revenues	`IncreaseDecreaseInDeferredRevenue`	$10.20B	USD	3 Qtrs
Unearned revenues	`IncreaseDecreaseInDeferredRevenue`	$12.22B	USD	3 Qtrs
Cash flows from operating activities	`NetCashProvidedByUsedInOperatingActivities`	$30.74B	USD	3 Qtrs
Cash flows from operating activities	`NetCashProvidedByUsedInOperatingActivities`	$34.26B	USD	3 Qtrs
Purchases of investments	`PaymentsToAcquireInvestments`	$13.00B	USD	3 Qtrs
Purchases of investments	`PaymentsToAcquireInvestments`	$14.18B	USD	3 Qtrs
Sales of investments	`ProceedsFromSaleOfAvailableForSaleSecuritiesDebt`	$3.67B	USD	3 Qtrs
Sales of investments	`ProceedsFromSaleOfAvailableForSaleSecuritiesDebt`	$5.38B	USD	3 Qtrs
Maturities of investments	`ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities`	$4.74B	USD	3 Qtrs
Maturities of investments	`ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities`	$6.47B	USD	3 Qtrs
Cash paid for acquisitions, net of cash assumed	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$8.39B	USD	3 Qtrs
Cash paid for acquisitions, net of cash assumed	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$7.15B	USD	3 Qtrs
Purchases of property, equipment and capitalized software	`PaymentsToAcquirePropertyPlantAndEquipment`	$2.43B	USD	3 Qtrs
Purchases of property, equipment and capitalized software	`PaymentsToAcquirePropertyPlantAndEquipment`	$1.94B	USD	3 Qtrs
Other, net	`PaymentsForProceedsFromOtherInvestingActivities`	$721.00M	USD	3 Qtrs
Other, net	`PaymentsForProceedsFromOtherInvestingActivities`	$-50.00M	USD	3 Qtrs
Cash flows used for investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-13.11B	USD	3 Qtrs
Cash flows used for investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-14.39B	USD	3 Qtrs
Common share repurchases	`PaymentsForRepurchaseOfCommonStock`	$6.00B	USD	3 Qtrs
Common share repurchases	`PaymentsForRepurchaseOfCommonStock`	$6.50B	USD	3 Qtrs
Cash dividends paid	`PaymentsOfDividendsCommonStock`	$1.74B	USD	Point-in-time
Cash dividends paid	`PaymentsOfDividendsCommonStock`	$1.75B	USD	Point-in-time
Cash dividends paid	`PaymentsOfDividendsCommonStock`	$5.02B	USD	3 Qtrs
Cash dividends paid	`PaymentsOfDividendsCommonStock`	$4.45B	USD	3 Qtrs
Cash dividends paid	`PaymentsOfDividendsCommonStock`	$1.54B	USD	Point-in-time
Proceeds from common stock issuances	`ProceedsFromIssuanceOfCommonStock`	$1.04B	USD	3 Qtrs
Proceeds from common stock issuances	`ProceedsFromIssuanceOfCommonStock`	$1.08B	USD	3 Qtrs
Repayments of long-term debt	`RepaymentsOfLongTermDebt`	$2.10B	USD	3 Qtrs
Repayments of long-term debt	`RepaymentsOfLongTermDebt`	$2.12B	USD	3 Qtrs
Proceeds from (repayments of) short-term borrowings, net	`ProceedsFromRepaymentsOfCommercialPaper`	$1.58B	USD	3 Qtrs
Proceeds from (repayments of) short-term borrowings, net	`ProceedsFromRepaymentsOfCommercialPaper`	$-16.00M	USD	3 Qtrs
Proceeds from issuance of long-term debt	`ProceedsFromIssuanceOfLongTermDebt`	$5.92B	USD	3 Qtrs
Proceeds from issuance of long-term debt	`ProceedsFromIssuanceOfLongTermDebt`	$6.39B	USD	3 Qtrs
Customer funds administered	`IncreaseDecreaseInDeposits`	$7.03B	USD	3 Qtrs
Customer funds administered	`IncreaseDecreaseInDeposits`	$2.04B	USD	3 Qtrs
Other, net	`ProceedsFromPaymentsForOtherFinancingActivities`	$-1.77B	USD	3 Qtrs
Other, net	`ProceedsFromPaymentsForOtherFinancingActivities`	$-1.63B	USD	3 Qtrs
Cash flows used for financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-166.00M	USD	3 Qtrs
Cash flows used for financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-4.37B	USD	3 Qtrs
Effect of exchange rate changes on cash and cash equivalents	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$4.00M	USD	3 Qtrs
Effect of exchange rate changes on cash and cash equivalents	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$49.00M	USD	3 Qtrs
Increase in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$17.47B	USD	3 Qtrs
Increase in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$15.55B	USD	3 Qtrs
Cash and cash equivalents, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$21.38B	USD	Point-in-time
Cash and cash equivalents, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$38.91B	USD	Point-in-time
Cash and cash equivalents, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$23.36B	USD	Point-in-time
Cash and cash equivalents, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$38.84B	USD	Point-in-time
Cash and cash equivalents, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$21.38B	USD	Point-in-time
Cash and cash equivalents, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$38.91B	USD	Point-in-time
Cash and cash equivalents, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$23.36B	USD	Point-in-time
Cash and cash equivalents, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$38.84B	USD	Point-in-time

Stockholders Equity 63 line items

Line Item	Tag	Value	Unit	Period
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$89.56B	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$87.37B	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$76.20B	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$81.45B	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$78.06B	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$75.05B	USD	Point-in-time
Balance (in shares)	`CommonStockSharesOutstanding`	925.00M	shares	Point-in-time
Balance (in shares)	`CommonStockSharesOutstanding`	934.00M	shares	Point-in-time
Net earnings attributable to UnitedHealth Group common shareholders	`NetIncomeLoss`	$5.26B	USD	1 Quarter
Net earnings attributable to UnitedHealth Group common shareholders	`NetIncomeLoss`	$15.36B	USD	3 Qtrs
Net earnings attributable to UnitedHealth Group common shareholders	`NetIncomeLoss`	$16.93B	USD	3 Qtrs
Net earnings attributable to UnitedHealth Group common shareholders	`NetIncomeLoss`	$5.84B	USD	1 Quarter
Net Earnings, Including Portion Attributable to Nonredeemable Noncontrolling Interest	`NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest`	$5.99B	USD	1 Quarter
Net Earnings, Including Portion Attributable to Nonredeemable Noncontrolling Interest	`NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest`	$15.64B	USD	3 Qtrs
Net Earnings, Including Portion Attributable to Nonredeemable Noncontrolling Interest	`NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest`	$5.36B	USD	1 Quarter
Net Earnings, Including Portion Attributable to Nonredeemable Noncontrolling Interest	`NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest`	$17.33B	USD	3 Qtrs
Other comprehensive (loss) income	`OtherComprehensiveIncomeLossNetOfTax`	$-295.00M	USD	3 Qtrs
Other comprehensive (loss) income	`OtherComprehensiveIncomeLossNetOfTax`	$-3.70B	USD	3 Qtrs
Other comprehensive (loss) income	`OtherComprehensiveIncomeLossNetOfTax`	$-1.36B	USD	1 Quarter
Other comprehensive (loss) income	`OtherComprehensiveIncomeLossNetOfTax`	$-1.04B	USD	1 Quarter
Issuances of common stock, and related tax effects	`StockIssuedDuringPeriodValueNewIssues`	$963.00M	USD	3 Qtrs
Issuances of common stock, and related tax effects	`StockIssuedDuringPeriodValueNewIssues`	$395.00M	USD	1 Quarter
Issuances of common stock, and related tax effects	`StockIssuedDuringPeriodValueNewIssues`	$801.00M	USD	3 Qtrs
Issuances of common stock, and related tax effects	`StockIssuedDuringPeriodValueNewIssues`	$294.00M	USD	1 Quarter
Share-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$163.00M	USD	1 Quarter
Share-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$639.00M	USD	3 Qtrs
Share-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$235.00M	USD	1 Quarter
Share-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$833.00M	USD	3 Qtrs
Common share repurchases	`StockRepurchasedAndRetiredDuringPeriodValue`	$6.00B	USD	3 Qtrs
Common share repurchases	`StockRepurchasedAndRetiredDuringPeriodValue`	$1.51B	USD	1 Quarter
Common share repurchases	`StockRepurchasedAndRetiredDuringPeriodValue`	$6.55B	USD	3 Qtrs
Common share repurchases	`StockRepurchasedAndRetiredDuringPeriodValue`	$1.00B	USD	1 Quarter
Cash dividends paid on common shares	`DividendsCash`	$1.74B	USD	1 Quarter
Cash dividends paid on common shares	`DividendsCash`	$4.45B	USD	3 Qtrs
Cash dividends paid on common shares	`DividendsCash`	$5.02B	USD	3 Qtrs
Cash dividends paid on common shares	`DividendsCash`	$1.54B	USD	1 Quarter
Redeemable noncontrolling interests fair value and other adjustments	`MinorityInterestChangeInRedemptionValue`	$-133.00M	USD	3 Qtrs
Redeemable noncontrolling interests fair value and other adjustments	`MinorityInterestChangeInRedemptionValue`	$239.00M	USD	3 Qtrs
Redeemable noncontrolling interests fair value and other adjustments	`MinorityInterestChangeInRedemptionValue`	$-42.00M	USD	1 Quarter
Redeemable noncontrolling interests fair value and other adjustments	`MinorityInterestChangeInRedemptionValue`	$5.00M	USD	1 Quarter
Acquisition and other adjustments of nonredeemable noncontrolling interests	`MinorityInterestPeriodIncreaseDecrease`	$32.00M	USD	1 Quarter
Acquisition and other adjustments of nonredeemable noncontrolling interests	`MinorityInterestPeriodIncreaseDecrease`	$135.00M	USD	3 Qtrs
Acquisition and other adjustments of nonredeemable noncontrolling interests	`MinorityInterestPeriodIncreaseDecrease`	$1.34B	USD	3 Qtrs
Acquisition and other adjustments of nonredeemable noncontrolling interests	`MinorityInterestPeriodIncreaseDecrease`	$42.00M	USD	1 Quarter
Distribution to nonredeemable noncontrolling interests	`MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders`	$283.00M	USD	3 Qtrs
Distribution to nonredeemable noncontrolling interests	`MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders`	$98.00M	USD	1 Quarter
Distribution to nonredeemable noncontrolling interests	`MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders`	$136.00M	USD	1 Quarter
Distribution to nonredeemable noncontrolling interests	`MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders`	$348.00M	USD	3 Qtrs
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$89.56B	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$87.37B	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$76.20B	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$81.45B	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$78.06B	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$75.05B	USD	Point-in-time
Balance (in shares)	`CommonStockSharesOutstanding`	925.00M	shares	Point-in-time
Balance (in shares)	`CommonStockSharesOutstanding`	934.00M	shares	Point-in-time
Common Stock, Dividends, Per Share, Cash Paid	`CommonStockDividendsPerShareCashPaid`	$1.65	USD	Point-in-time
Common Stock, Dividends, Per Share, Cash Paid	`CommonStockDividendsPerShareCashPaid`	$5.41	USD	3 Qtrs
Common Stock, Dividends, Per Share, Cash Paid	`CommonStockDividendsPerShareCashPaid`	$1.88	USD	Point-in-time
Common Stock, Dividends, Per Share, Cash Paid	`CommonStockDividendsPerShareCashPaid`	$1.65	USD	1 Quarter
Common Stock, Dividends, Per Share, Cash Paid	`CommonStockDividendsPerShareCashPaid`	$1.88	USD	1 Quarter
Common Stock, Dividends, Per Share, Cash Paid	`CommonStockDividendsPerShareCashPaid`	$4.75	USD	3 Qtrs
Common Stock, Dividends, Per Share, Cash Paid	`CommonStockDividendsPerShareCashPaid`	$1.88	USD	Point-in-time

Comprehensive Income 48 line items

Line Item	Tag	Value	Unit	Period
Net earnings	`ProfitLoss`	$17.47B	USD	3 Qtrs
Net earnings	`ProfitLoss`	$15.73B	USD	3 Qtrs
Net earnings	`ProfitLoss`	$5.38B	USD	1 Quarter
Net earnings	`ProfitLoss`	$6.04B	USD	1 Quarter
Gross unrealized losses on investment securities during the period	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax`	$-1.47B	USD	1 Quarter
Gross unrealized losses on investment securities during the period	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax`	$-893.00M	USD	1 Quarter
Gross unrealized losses on investment securities during the period	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax`	$-4.83B	USD	3 Qtrs
Gross unrealized losses on investment securities during the period	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax`	$-684.00M	USD	3 Qtrs
Income tax effect	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax`	$-156.00M	USD	3 Qtrs
Income tax effect	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax`	$-1.11B	USD	3 Qtrs
Income tax effect	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax`	$-204.00M	USD	1 Quarter
Income tax effect	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax`	$-340.00M	USD	1 Quarter
Total unrealized losses, net of tax	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-689.00M	USD	1 Quarter
Total unrealized losses, net of tax	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-528.00M	USD	3 Qtrs
Total unrealized losses, net of tax	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-3.72B	USD	3 Qtrs
Total unrealized losses, net of tax	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-1.13B	USD	1 Quarter
Gross reclassification adjustment for net realized losses (gains) included in net earnings	`OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax`	$-138.00M	USD	1 Quarter
Gross reclassification adjustment for net realized losses (gains) included in net earnings	`OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax`	$-134.00M	USD	3 Qtrs
Gross reclassification adjustment for net realized losses (gains) included in net earnings	`OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax`	$-7.00M	USD	1 Quarter
Gross reclassification adjustment for net realized losses (gains) included in net earnings	`OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax`	$27.00M	USD	3 Qtrs
Income tax effect	`OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax`	$-31.00M	USD	3 Qtrs
Income tax effect	`OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax`	$-2.00M	USD	1 Quarter
Income tax effect	`OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax`	$-32.00M	USD	1 Quarter
Income tax effect	`OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax`	$6.00M	USD	3 Qtrs
Total reclassification adjustment, net of tax	`OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax`	$-106.00M	USD	1 Quarter
Total reclassification adjustment, net of tax	`OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax`	$-5.00M	USD	1 Quarter
Total reclassification adjustment, net of tax	`OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax`	$21.00M	USD	3 Qtrs
Total reclassification adjustment, net of tax	`OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax`	$-103.00M	USD	3 Qtrs
Total foreign currency translation (losses) gains	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax`	$-331.00M	USD	1 Quarter
Total foreign currency translation (losses) gains	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax`	$-89.00M	USD	3 Qtrs
Total foreign currency translation (losses) gains	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax`	$-354.00M	USD	1 Quarter
Total foreign currency translation (losses) gains	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax`	$254.00M	USD	3 Qtrs
Other comprehensive loss	`OtherComprehensiveIncomeLossNetOfTax`	$-295.00M	USD	3 Qtrs
Other comprehensive loss	`OtherComprehensiveIncomeLossNetOfTax`	$-3.70B	USD	3 Qtrs
Other comprehensive loss	`OtherComprehensiveIncomeLossNetOfTax`	$-1.36B	USD	1 Quarter
Other comprehensive loss	`OtherComprehensiveIncomeLossNetOfTax`	$-1.04B	USD	1 Quarter
Comprehensive income	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$17.17B	USD	3 Qtrs
Comprehensive income	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$12.03B	USD	3 Qtrs
Comprehensive income	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$5.00B	USD	1 Quarter
Comprehensive income	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$4.03B	USD	1 Quarter
Comprehensive income attributable to noncontrolling interests	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$543.00M	USD	3 Qtrs
Comprehensive income attributable to noncontrolling interests	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$122.00M	USD	1 Quarter
Comprehensive income attributable to noncontrolling interests	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$372.00M	USD	3 Qtrs
Comprehensive income attributable to noncontrolling interests	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$197.00M	USD	1 Quarter
Comprehensive income attributable to UnitedHealth Group common shareholders	`ComprehensiveIncomeNetOfTax`	$11.66B	USD	3 Qtrs
Comprehensive income attributable to UnitedHealth Group common shareholders	`ComprehensiveIncomeNetOfTax`	$4.80B	USD	1 Quarter
Comprehensive income attributable to UnitedHealth Group common shareholders	`ComprehensiveIncomeNetOfTax`	$16.63B	USD	3 Qtrs
Comprehensive income attributable to UnitedHealth Group common shareholders	`ComprehensiveIncomeNetOfTax`	$3.91B	USD	1 Quarter

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.